Il-β a potential factor for discriminating between thyroid carcinoma and atrophic thyroiditis

European Cytokine Network

Volumn 23, Issue 3, 2012, Pages 101-106

  Kammoun Krichen, Maha ^a,b   Bougacha Elleuch, Noura ^a,b   Mnif, Mouna ^a,c   Bougacha, Fadia ^b   Charffedine, Ilhem ^d   Rebuffat, Sandra ^a,e   Rebai, Ahmed ^b   Glasson, Emilie ^f   Abid, Mohamed ^c   Ayadi, Fatma ^d   Péraldi Roux, Sylvie ^a,e   Ayadi, Hammadi ^a,b  

^a LIA135 CNRS   (France)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^c HEDI CHAKER HOSPITAL   (Tunisia)

^d HABIB BOURGUIBA HOSPITAL   (Tunisia)

^e Centre de pharmacologie et innovation dans le diabète UMR5232   (France)

^f CNRS   (France)

Author keywords

Bioplex; Cytokines; Il ; Thyroid

Indexed keywords

ANTIBODY; INTERLEUKIN 1BETA; THYMOCYTE ANTIBODY; THYROTROPIN; THYROXINE; TPO ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; THYROID HORMONE;

ARTICLE; ATROPHIC THYROIDITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; NODULAR GOITER; THYROID CARCINOMA; THYROIDITIS; ATROPHY; BLOOD; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; PATHOLOGY; THYROID GLAND; THYROID TUMOR;

ATROPHY; AUTOANTIBODIES; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTERLEUKIN-1BETA; THYROID GLAND; THYROID HORMONES; THYROID NEOPLASMS; THYROIDITIS;

EID: 84868154967     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0312     Document Type: Article

References (22)

1. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. 1993 Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164:658-61.
2. Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; 148(1): 1-9.
3. Ajjan RA,Watson PF,Weetman AP. Cytokines and thyroid function. Adv Neuroimmunol 1996; 6(4): 359-86.
4. Lin JD, Chao TC, Weng HF, Lin KD. The roles of cytokines and retinoic acid in the regulation of human thyroid cancer cell growth. Cytokine 1998; 10(7): 536-9.
5. Mine M, Tramontano D, Chin WW, Ingbar SH. Interleukin-1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture. Endocrinology 1987; 120(3): 1212-4.
6. Enomoto T, Sugawa H, Kosugi S, Inoue D, Mori T, Imura H. Prolonged effects of recombinant human interleukin-1 alpha on mouse thyroid Function. Endocrinology 1992; 127: 2322.
7. Migita K, Eguchi K, Otsubo T, et al. Cytokine regulation of HLA on thyroid epithelial cells. Clin Exp Immunol 1990; 82(3): 548-52.
8. Diamant M, Kayser L, Rasmussen AK, Bech K, Feldt-Rassmussen U. Interleukin-6 production by thyroid epithelial cells. Enhancement by interleukin-1. Autoimmunity 1991; 11(1):21-6.
9. Weetman AP, Bennett GL, Wong WL. Thyroid follicular cells produce interleukin-8. J Clin Endocrinol Metab 1992; 75(1): 328-30.
10. Nilsson M, Husmark J, Björkman U, Ericson LE. Cytokines and thyroid epithelial integrity: interleukin-1alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 1998; 83(3): 945-52.
11. Kammoun-Krichen M, Bougacha-Elleuch N, Makni K, et al. Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur Cytokine Netw 2007; 18(4): 196-200.
12. Kammoun-Krichen M, Bougacha-Elleuch N, Rebai A, Mnif M, Abid M, Ayadi H. TNF gene polymorphisms in Graves' disease: TNF-308 A/G meta-analysis. Ann Hum Biol 2008; 35(6): 656-61.s
13. Linkov F, Ferris RL, Yurkovetsky Z, et al. Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases. Proteomics Clin Appl 2008 10;2(12):1575-85.
14. Yamashita S, Kimura H, Ashizawa K, et al. Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J Endocrinol 1989; 122: 77.
15. Ashizawa K, Yamashita S, Tobinaga T, et al. Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol (Copenh) 1989; 4: 465.
16. Sato K, Satoh T, Shizume K, et al. Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990; 70: 1735.
17. Ajjan RA, Watson PF, Findlay C, et al. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol 1998; 158: 351.
18. Shi Y, Wang H, Su Z, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand J Immunol 2010; 72(3): 250-5.
19. Zorin NA, Maklakova TP, Appel'gans TV, Arkhipova SV, Bichan IV. Hormones, cytokines and macroglobulines in blood of women with autoimmune thyroid diseases. Ter Arkh 2008; 80(11): 61-3.
20. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Euroimmunomodulation 2004, 11:209-13.
21. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2003; 59(2): 207-213.
22. Bossowski A, Urban M. Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic nodular goiter. J Pediatr Endocrinol Metab 2001; 14(6): 741-7.